Kesios Therapeutics Ltd. logo

Kesios Therapeutics Ltd.

The company is focused on the discovery and development of novel drug candidates for the treatment of multiple myeloma and other malignancies which target aberrant NF-κB signaling, via a novel drug target (the GADD45β/MKK7 complex).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.kesios.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
30 Broad Street, Great Cambourne,Cambridgeshire,CB23 6HJ
Cambridge
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/kesios-therapeutics” connections=”true” suffix=””]